M Nishikawa, JC Mak, H Shirasaki, SE Harding and PJ Barnes
Department of Thoracic Medicine, Royal Bromptom National Heart and Lung Institute, London, United Kingdom.

We studied the down-regulation of beta 2-adrenoceptors in guinea pig lung after chronic exposure to a beta-agonist. Guinea pigs were exposed to either norepinephrine (NE) or vehicle for 7 days. The density and affinity of beta-adrenoceptors were determined by Scatchard analysis of [125I]cyanopindolol binding in a lung membrane preparation and beta 1- and beta 2-adrenoceptor subtypes were studied in the presence of 0.1 microM ICI 118,551, a selective beta 2-adrenoceptor antagonist, or 0.1 microM CGP 20712 A, a selective beta 1-adrenoceptor antagonist, respectively. beta 2-Adrenoceptor mRNA was examined by Northern blot analysis. The tissue distribution of beta 2-adrenoceptors and of beta 2- adrenoceptor mRNA in lung after NE infusion were determined using receptor autoradiography and in situ hybridization, respectively. The functional significance of the decrease in beta 2-adrenoceptor was tested by measuring the relaxation response to a beta 2-agonist in isolated parenchymal strips. NE treatment resulted in decreases of 75 +/- 9%, 84 +/- 4%, and 66 +/- 9% of total beta-, beta 1-, and beta 2- adrenoceptors in the lung, compared with control animals. The administration of NE had only minimal effects on the dissociation constant (Kd) of the receptor for the radioligand. beta 2-Adrenoceptors mRNA was decreased by 46 +/- 13% after NE treatment. There was a correspondence between the distribution of beta 2-adrenoceptors and beta 2-adrenoceptor mRNA localization in both control and NE-treated guinea pigs. NE treatment reduced alveolar beta 2-adrenoceptors by 70 +/- 3% and its mRNA expression by 78 +/- 5%.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				G. A. Hawkins, K. Tantisira, D. A. Meyers, E. J. Ampleford, W. C. Moore, B. Klanderman, S. B. Liggett, S. P. Peters, S. T. Weiss, and E. R. Bleecker Sequence, Haplotype, and Association Analysis of ADRbeta2 in a Multiethnic Asthma Case-Control Study Am. J. Respir. Crit. Care Med., November 15, 2006; 174(10): 1101 - 1109. [Abstract] [Full Text] [PDF]

				A.-L. Leoni, C. Marionneau, S. Demolombe, S. L. Bouter, M. E. Mangoni, D. Escande, and F. Charpentier Chronic heart rate reduction remodels ion channel transcripts in the mouse sinoatrial node but not in the ventricle Physiol Genomics, December 14, 2005; 24(1): 4 - 12. [Abstract] [Full Text] [PDF]

				S. Andreas, S. D. Anker, P. D. Scanlon, and V. K. Somers Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease Chest, November 1, 2005; 128(5): 3618 - 3624. [Abstract] [Full Text] [PDF]

				J. M. Liebler, Z. Borok, X. Li, B. Zhou, A. J. Sandoval, K.-J. Kim, and E. D. Crandall Alveolar Epithelial Type I Cells Express {beta}2-Adrenergic Receptors and G-protein Receptor Kinase 2 J. Histochem. Cytochem., June 1, 2004; 52(6): 759 - 767. [Abstract] [Full Text] [PDF]

				P.J. Barnes Scientific rationale for inhaled combination therapy with long-acting {beta}2-agonists and corticosteroids Eur. Respir. J., January 1, 2002; 19(1): 182 - 191. [Abstract] [Full Text] [PDF]

				H. Kume, S. Ito, Y. Ito, and K. Yamaki Role of Lysophosphatidylcholine in the Desensitization of beta -Adrenergic Receptors by Ca2+ Sensitization in Tracheal Smooth Muscle Am. J. Respir. Cell Mol. Biol., September 1, 2001; 25(3): 291 - 298. [Abstract] [Full Text] [PDF]

				D.C. Grootendorst, P.J. Sterk, and H.G.M. Heijerman Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma Eur. Respir. J., March 1, 2001; 17(3): 374 - 379. [Abstract] [Full Text] [PDF]

				A Kamachi, M Munakata, Y Nasuhara, M Nishimura, Y Ohtsuka, M Amishima, T Takahashi, Y Homma, and Y Kawakami Enhancement of goblet cell hyperplasia and airway hyperresponsiveness by salbutamol in a rat model of atopic asthma Thorax, January 1, 2001; 56(1): 19 - 24. [Abstract] [Full Text]

				P. E. MOORE, J. D. LAPORTE, J. H. ABRAHAM, I. N. SCHWARTZMAN, C. N. YANDAVA, E. S. SILVERMAN, J. M. DRAZEN, M. P. WAND, R. A. PANETTIERI Jr., and S. A. SHORE Polymorphism of the {beta}2-Adrenergic Receptor Gene and Desensitization in Human Airway Smooth Muscle Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2117 - 2124. [Abstract] [Full Text]

				M. M. Borst, W. Beuthien, C. Schwencke, P. LaRosee, R. Marquetant, M. Haass, W. Kubler, and R. H. Strasser Desensitization of the pulmonary adenylyl cyclase system: A cause of airway hyperresponsiveness in congestive heart failure? J. Am. Coll. Cardiol., September 1, 1999; 34(3): 848 - 856. [Abstract] [Full Text] [PDF]

				P. D. Charron, J. P. Fawley, and M. B. Maron Effect of epinephrine on alveolar liquid clearance in the rat J Appl Physiol, August 1, 1999; 87(2): 611 - 618. [Abstract] [Full Text] [PDF]

				H. KUME and K. TAKAGI Inhibition of beta -Adrenergic Desensitization by KCa Channels in Human Trachealis Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 452 - 460. [Abstract] [Full Text]

				D. CHEUNG, A. M. J. WEVER, J. A. de GOEIJ, C. S. de GRAAFF, H. STEEN, and P. J. STERK Effects of Theophylline on Tolerance to the Bronchoprotective Actions of Salmeterol in Asthmatics In Vivo Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 792 - 796. [Abstract] [Full Text] [PDF]

				S. Mitra, M. Ugur, O. Ugur, H. M. Goodman, J. R. McCullough, and H. Yamaguchi (S)-Albuterol Increases Intracellular Free Calcium by Muscarinic Receptor Activation and a Phospholipase C-Dependent Mechanism in Airway Smooth Muscle Mol. Pharmacol., March 1, 1998; 53(3): 347 - 354. [Abstract] [Full Text]

				H. INOUE, H. AIZAWA, K. MATSUMOTO, M. SHIGYO, S. TAKATA, M. HARA, and N. HARA Effect of beta 2-agonists on Histamine-induced Airway Microvascular Leakage in Ozone-exposed Guinea Pigs Am. J. Respir. Crit. Care Med., September 1, 1997; 156(3): 723 - 727. [Abstract] [Full Text] [PDF]